The earnings call highlighted revenue growth, strong gross margins, and strategic market expansions. However, challenges in the North American market, reduced guidance, and increased operating expenses were noted as significant concerns.

Company Guidance

During InMode's Second Quarter 2025 Earnings Call, the company provided guidance reflecting a challenging market environment, particularly in North America, due to reduced personnel spending and fewer treatments. InMode reported Q2 revenues of $95.6 million, with a gross margin of 80% on a GAAP basis. Sales outside the U.S. contributed $45 million, marking an 11% increase year-over-year, with Europe leading at $23 million. The company adjusted its 2025 revenue guidance to $365-$375 million, down from the previous $395-$405 million, citing lower-than-expected performance in the first half of the year. Non-GAAP gross margins are expected to remain between 78% and 80%, with non-GAAP earnings per diluted share forecasted between $1.55 and $1.59. Despite these challenges, InMode remains committed to its long-term strategy, focusing on market expansion, product launches, and maintaining a strong balance sheet with cash and equivalents amounting to $510.7 million as of June 30, 2025.

Revenue Growth

InMode generated revenues of $95.6 million in Q2 2025, up from $86.4 million in the same quarter last year, excluding previous preorders.

Expansion into New Markets

Strategic expansion with new direct operations in Thailand and Argentina to enhance local presence, improve customer support, and streamline operations.

Strong Gross Margin

Gross margin remained strong at 80% on a GAAP basis, consistent with Q2 2024.

International Sales Growth

Sales outside of the U.S. accounted for $45 million or 48% of overall sales, an 11% increase year-over-year, with Europe being the largest contributor.

New Product Launch

Launch of platforms in the wellness space focused on increased blood circulation and pain relief for the urology community, with full commercial rollout expected in Q4.

Improved Operating Margin

GAAP operating margin increased to 24% from 21% in Q2 2024.

InMode (INMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

INMD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 22, 2025	2025 (Q3)	0.34 / -	0.7	―	―	―
Jul 30, 2025	2025 (Q2)	0.41 / 0.47	0.34	38.24% (+0.13)
Apr 28, 2025	2025 (Q1)	0.35 / 0.31	0.32	-3.13% (-0.01)
Feb 04, 2025	2024 (Q4)	0.53 / 0.42	0.71	-40.85% (-0.29)
Oct 30, 2024	2024 (Q3)	0.57 / 0.70	0.61	14.75% (+0.09)
Aug 01, 2024	2024 (Q2)	0.38 / 0.34	0.72	-52.78% (-0.38)
May 02, 2024	2024 (Q1)	0.43 / 0.32	0.52	-38.46% (-0.20)
Feb 13, 2024	2023 (Q4)	0.66 / 0.71	0.78	-8.97% (-0.07)
Nov 02, 2023	2023 (Q3)	0.64 / 0.61	0.66	-7.58% (-0.05)
Jul 27, 2023	2023 (Q2)	0.65 / 0.72	0.59	22.03% (+0.13)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

INMD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 30, 2025	$14.31	$13.90	-2.87%
Apr 28, 2025	$16.22	$14.26	-12.08%
Feb 04, 2025	$16.67	$17.50	+4.98%
Oct 30, 2024	$17.91	$17.87	-0.22%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.